Lion Chemtech Co., Ltd. (KOSDAQ:171120)
South Korea · Delayed Price · Currency is KRW 2,085.00
+15.00 (0.72%)
At close: Aug 14, 2026
Lion Chemtech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 141,793 | 130,272 | 141,812 | 130,783 | 152,001 | 150,416 |
Other Revenue | -0 | -0 | - | -0 | -0 | - |
| 141,793 | 130,272 | 141,812 | 130,783 | 152,001 | 150,416 | |
Revenue Growth | 0.94% | -8.14% | 8.43% | -13.96% | 1.05% | - |
Cost of Revenue | 110,924 | 105,002 | 115,291 | 107,167 | 121,051 | 123,735 |
Gross Profit | 30,869 | 25,270 | 26,522 | 23,615 | 30,949 | 26,681 |
Selling, General & Admin | 12,777 | 13,681 | 14,270 | 13,127 | 17,663 | 14,655 |
Research & Development | 605.64 | 759.31 | 991.21 | 804.5 | 852.93 | 810.7 |
Amortization of Goodwill & Intangibles | 8.96 | 17 | 58.15 | 58.93 | 63.03 | 67.89 |
Other Operating Expenses | 504.55 | 570.45 | 516.88 | 611.09 | 560.42 | 518.1 |
Operating Expenses | 13,569 | 14,179 | 17,145 | 15,820 | 19,963 | 17,250 |
Operating Income | 17,301 | 11,091 | 9,376 | 7,795 | 10,986 | 9,431 |
Interest Expense | -389.7 | -435.44 | -484.79 | -1,290 | -413.55 | -170.17 |
Interest & Investment Income | 1,164 | 1,039 | 1,593 | 1,796 | 423.73 | 142.04 |
Currency Exchange Gain (Loss) | 881.34 | -90.69 | 3,809 | 1,210 | 1,142 | 2,242 |
Other Non Operating Income (Expenses) | 66.43 | 53.09 | -3,323 | -963.6 | 225.48 | 234.63 |
EBT Excluding Unusual Items | 19,023 | 11,657 | 10,970 | 8,547 | 12,364 | 11,879 |
Gain (Loss) on Sale of Investments | 74.94 | 262.72 | 286.03 | 487.57 | -796.28 | 185.05 |
Gain (Loss) on Sale of Assets | -6.73 | -6.73 | 43.39 | -0 | 469.68 | 16.37 |
Asset Writedown | - | - | - | - | -73.28 | -1,320 |
Other Unusual Items | - | - | 313.02 | - | - | - |
Pretax Income | 19,091 | 11,913 | 11,612 | 9,034 | 11,964 | 10,761 |
Income Tax Expense | 4,229 | 3,417 | 2,789 | 1,951 | 3,116 | 2,241 |
Net Income | 14,862 | 8,496 | 8,824 | 7,083 | 8,848 | 8,520 |
Net Income to Common | 14,862 | 8,496 | 8,824 | 7,083 | 8,848 | 8,520 |
Net Income Growth | 200.48% | -3.71% | 24.57% | -19.95% | 3.85% | - |
Shares Outstanding (Basic) | 35 | 35 | 35 | 36 | 36 | 36 |
Shares Outstanding (Diluted) | 35 | 35 | 35 | 36 | 36 | 36 |
Shares Change | -0.20% | 0.00% | -1.69% | -0.00% | - | - |
EPS (Basic) | 421.58 | 240.71 | 250.00 | 197.30 | 246.45 | 237.31 |
EPS (Diluted) | 421.58 | 240.71 | 250.00 | 197.00 | 246.45 | 237.31 |
EPS Growth | 201.07% | -3.72% | 26.90% | -20.06% | 3.85% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 17,251 | 20,327 | 2,332 | 8,133 | 7,594 | 469.25 |
Free Cash Flow Per Share | 489.35 | 575.91 | 66.06 | 226.53 | 211.51 | 13.07 |
Dividend Per Share | - | - | - | 100.000 | 75.000 | 100.000 |
Dividend Growth | - | - | - | 33.33% | -25.00% | - |
Gross Margin | 21.77% | 19.40% | 18.70% | 18.06% | 20.36% | 17.74% |
Operating Margin | 12.20% | 8.51% | 6.61% | 5.96% | 7.23% | 6.27% |
Profit Margin | 10.48% | 6.52% | 6.22% | 5.42% | 5.82% | 5.66% |
Free Cash Flow Margin | 12.17% | 15.60% | 1.64% | 6.22% | 5.00% | 0.31% |
EBITDA | 19,242 | 13,095 | 12,328 | 11,109 | 14,192 | 12,590 |
EBITDA Margin | 13.57% | 10.05% | 8.69% | 8.49% | 9.34% | 8.37% |
D&A For EBITDA | 1,941 | 2,004 | 2,951 | 3,314 | 3,206 | 3,159 |
EBIT | 17,301 | 11,091 | 9,376 | 7,795 | 10,986 | 9,431 |
EBIT Margin | 12.20% | 8.51% | 6.61% | 5.96% | 7.23% | 6.27% |
Effective Tax Rate | 22.15% | 28.68% | 24.02% | 21.59% | 26.05% | 20.82% |
Advertising Expenses | - | 319.93 | 216.97 | 465.9 | 259.8 | 265.64 |